Stem Cell Therapy care in South Africa
Hospitals and medical centers in South Africa performing Stem Cell Therapy for Stroke victims.
Key planning information for stroke stem cell therapy in South Africa.
Stroke Stem Cell Therapy in South Africa is priced per case at 2 hospitals. Each hospital quotes its own price for your case.
Stroke Stem Cell Therapy is listed by 2 hospitals in South Africa. The order reshuffles every hour so each gets equal exposure.
Hospital GroupLife Healthcare is a leading private hospital operator in South Africa and primarily serves the market for privately insured individuals, representing approximately eight million people. The group provides mainly acute care, high technology private hospital services.
Stroke is treated at
Hospital GroupNetcare Group provides innovative, quality healthcare in South Africa and the United Kingdom.
Stroke is treated at
Ischemic stroke is the most common form of stroke and it occurs when oxygen-rich blood is blocked from reaching the brain, usually due to blood clots. Hemorrhagic stroke occurs due to ruptured or leaking blood vessels in the brain. How stroke affects a person varies depending on what side of the brain is affected and the extent of damage caused. Some patients may lose the ability to walk or speak and others may experience temporary leg or arm weakness.
Tissue plasminogen activator (tPA) is the most common treatment for ischemic stroke which dissolves the blood clot preventing the blood flow to reach the brain. However, tPA treatment has to be given within hours of the occurrence of the stroke which is often exceeded due to the time it takes the patient to arrive at a hospital.
Although the SB623 cells live for around a month researchers have noted that improvement continues to show for several months. It is thought that soon after they are implanted, the SB623 cells secrete deposits near the damaged tissues and the deposits boost regeneration and reactivation of nerve tissue which serves to improve motor function.
Mesenchymal stem cells are the commonly used stem cells in the treatment of stroke. This is because they are not rejected by the donor’s immune system despite being harvested from the bone marrow of donors. Mesenchymal stem cells occur naturally in the muscles, bone, fat and tendon tissues. They are easily harvested from bone marrow and they usually do not trigger a strong immune reaction in patients even when they are from an unrelated donor. Moreover, they may cause an active suppression of the immune system.
The adult stem cells are injected directly into the stroke patient’s brains This method has proven to be both safe and effective in the restoration of motor function. The procedure is typically performed when the patient is conscious but under light anesthesia. It involves drilling a small hole through the patient’s skull. The patient’s head is held in a fixed position while the hole is drilled to allow the SB623 cells to be injected which is accomplished with a syringe. The cells are injected into a number of spots at the periphery of the area damaged by the stroke which varies with each patient.
After the procedure, the patient is monitored through blood tests, brain imaging, and clinical evaluations. The patient is usually discharged the next day.
Motor-function improvements
Substantial improvements have been seen in stroke patients who had previously lost most motor function and were in wheelchairs and who could now walk. The improvement after the operation was seen to be independent of the patient’s age or the stroke’s severity.
Key facts to plan your treatment: how long it takes, your hospital stay, anaesthesia, risks and recovery.
Common questions
Have a question? Get a free consultation.
Choose a hospital and send your enquiry to its international patient team. Each replies with its own price and plan.
Free consultation • No obligation